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Abstract
Background: Control of tuberculosis (TB) depends on early diagnosis and treatment at the primary health care
level. However, many patients are still diagnosed late with TB at hospitals. The present study aimed to investigate
the delay in diagnosis of TB patients at the emergency department.
Methods: This was a prospective study in a general, tertiary care, university-affiliated hospital of a city with a high
prevalence of TB in Brazil. New TB patients ≥ 14 years diagnosed with pulmonary TB at the emergency department
of Hospital de Clínicas de Porto Alegre were prospectively recruited between February 2010 and January 2012. The
consenting patients meeting our inclusion criteria were interviewed using a pre-tested questionnaire. We evaluated
the delay in time until diagnosis and identified factors associated with delayed diagnosis (patient and health care
system delays).
Results: We included 153 patients. The median total time of delay, patient delay, and health care system delay
were 60 (interquartile range [IQR]: 30–90.5 days), 30 (lQR: 7–60 days), and 18 (IQR: 9–39.5 days) days, respectively.
The factors that were independently associated with patient delay (time ≥ 30 days) were crack (odds ratio [OR] = 4.88,
p = 0.043) and cocaine (OR = 6.68, p = 0.011) use. The factors that were independently associated with health care
system delay (time ≥ 18 days) were weight loss (OR = 2.76, p = 0.025), miliary pattern (OR = 5.33, p = 0.032), and fibrotic
changes (OR = 0.12, p = 0.013) on chest X-ray.
Conclusions: Patient delay appears to be the main problem in this city with a high prevalence of TB in Brazil. The main
factor associated with patient delay is drug abuse (crack and cocaine). Our study shows substance abuse programs
need to be aware of control of TB, with health interventions focusing on TB education programs.
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Background
Tuberculosis (TB) is an infectious disease caused by
Mycobacterium tuberculosis and remains a public health
problem worldwide. Approximately 2 billion people, repre-
senting one third of the world’s population, are infected
with TB. Eight million people develop active disease each
year, resulting in 2 million deaths from TB annually. Brazil
is ranked 17th among 22 countries, and has the highest re-
ported incidence of TB, with 42 cases/100,000 inhabitants
in 2011 [1]. The city of Porto Alegre in southern Brazil had
a rate of incidence of TB in 104 cases/100,000 inhabitants/
year in 2011 [2].
Control of TB in the community depends on early
diagnosis and treatment. In regions with a high preva-
lence of TB, an early diagnosis is considered as one per-
formed between 2 to 3 weeks after the onset of clinical
symptoms and a late diagnosis is that performed 4 weeks
after this onset [3]. Therefore, an acceptable time delay
in diagnosis of 3 or 4 weeks would be effective for dis-
ease control [4]. The total diagnosis delay is the sum of
patient delay, and health system delay. The reported ranges
of the average (median or mean) total diagnosis delay, pa-
tient delay, and health system delay are 25–185 days, 4.9–
162 days, and 2–87 days, respectively, for low, middle, and
high income countries [5].
The reasons for delay in diagnosis reflect factors related
to the patient and the health care system. Factors related to
the health system vary according to each country or region
[6]. The factors related to the individual involve personal
characteristics, and socioeconomic and demographic fac-
tors [6,7]. The main factors associated with diagnostic delay
include human immunodeficiency virus (HIV) infection, a
negative sputum smear, extrapulmonary TB, old age, female
sex, alcoholism and substance abuse, low education level,
coexistence of chronic cough and/or other lung diseases,
rural residence, low access, low awareness of TB, among
others [6]. In studies conducted in Brazil, female sex, cough,
unemployment, and the inability to recognize symptoms as
indicators of disease are factors independently associated
with patient delay [8,9]. In addition, only female sex is inde-
pendently associated with health care system delay [8]. Fur-
thermore, unemployment, having given up smoking, and
having lost weight are associated with total delay (patient
and health care system delays) [10].
Understanding the factors related to delay in diagnosis
of disease is essential to reduce the period of transmis-
sion, reduce the risk of exposure of other community
members, and thus facilitate disease control. Few studies
have evaluated these factors in tertiary care hospitals in
regions with a high incidence of TB and HIV [6,11]. The
objective of this study was to investigate the delay in
diagnosis of TB patients at the emergency department
(ED) of a tertiary care hospital, and to analyze factors as-
sociated with patient and health care system delays.
Methods
Study design and setting
We conducted a prospective study at the ED of the Hos-
pital de Clinicas de Porto Alegre (HCPA). The HCPA is
a tertiary hospital and a reference center for HIV patients
in South Brazil. Porto Alegre is among the Brazilian cities
with the highest incidence of TB, with 2123 cases regis-
tered in 2011, 200 deaths in patients co-infected with
TB-HIV, and 50 deaths in patients who were HIV negative
[2]. Furthermore, Porto Alegre has a TB-HIV co-infection
rate of 35% [12]. In Brazil, the public health system pro-
vides TB health services and treatment free of charge at
hospitals and health centers.
Participants
The study population consisted of patients diagnosed
with TB at the ED. Patients aged more than 14 years, di-
agnosed as new cases of pulmonary TB (with or without
extrapulmonary TB), according to consensus criteria [13],
were included in the study. The study was approved by
the Research Ethics Committee of the HCPA (protocol
09–575). All patients or their legal guardians gave written
informed consent to participate.
Pulmonary TB was diagnosed according to any of
the following criteria established by the Brazilian Guide-
lines for Tuberculosis [13]: 1) detection by a direct test
(Ziehl-Neelsen [ZN] method) with two positive samples;
2) detection by a direct test (ZN method) with one positive
sample and a positive culture result for M. tuberculosis
(in Löwenstein-Jensen [LJ] medium); 3) detection by a dir-
ect test (ZN method) with one positive sample and radio-
logical findings compatible with TB; 4) only a positive
culture result for M. tuberculosis (in LJ medium); or 5) the
presence of clinical, epidemiological, and radiographic find-
ings compatible with TB. Patients who failed to respond to
questionnaires and those who refused to sign the consent
form were excluded from the study.
Data collection
For data collection, we used a standardized and pre-tested
questionnaire with open and closed questions. The inter-
views were conducted by three interviewers who were pre-
viously trained at the time of admission. Factors that could
be associated with delay in seeking care at health services,
and delay in diagnosis and initiation of treatment for TB
were collected. These factors included demographic char-
acteristics, such as age (years), sex (male/female), ethnicity
(white/non-white race), income (monthly household in-
come), and education level (years of schooling). Behavioral
characteristics included (1) smoking status as follows. Re-
spondents who reported smoking at least 100 cigarettes in
their lifetime and who, at the time of survey, smoked either
every day or some days were defined as current smokers.
Respondents who reported smoking at least 100 cigarettes
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in their lifetime and who, at the time of the survey, did not
smoke at all were defined as former smokers. Respondents
who reported never having smoked 100 cigarettes were de-
fined as never smokers. (2) Alcohol use was investigated
where alcohol abuse was defined as daily consumption
of at least 30 g of alcohol for men and 24 g for women.
(3) Drug use was defined as any use in the past 6 months.
(4) Self-medication use was recorded. Clinical features of
the disease included the clinical form of TB (pulmonary or
pleuropulmonary), symptoms (cough, sputum production,
night sweats, weight loss, fever, dyspnea, hemoptysis, chest
pain, and fatigue), time since the first symptom, HIV status
(patients were tested for HIV at the discretion of the ER
physician), non-HIV immunosuppression (chronic renal
failure, malignant tumors, transplant recipients, and those
using prednisone or an equivalent [at a dose ≥ 15 mg/day
for 4 weeks]), immunosuppressants (for 4 weeks or longer)
or biological modifiers, such as etanercept and infliximab.
Services sought before the ED (if yes or no, and the num-
ber of services sought), and the history of previous TB (and
if the patient completed at least 6 months of treatment)
were also collected. The diagnostic method (spontaneous
sputum, induced sputum, and bronchoalveolar lavage) and
chest X-ray results were obtained from the electronic med-
ical records.
Patients were asked to estimate the time in days from
onset of symptoms to the first clinical care (any clini-
cians, not only in the ED). The total time of delay was
defined as the period from the beginning of any symp-
toms until the use of at least three antituberculosis
drugs. Patient delay was defined as the period from the
beginning of any symptoms of TB until the first medical
care. Health system delay was defined as the period from
the first medical care until the beginning of at least three
antituberculosis drugs.
Sample size calculation and statistical analysis
Calculation of sample size was performed based on a
study by Ward et al. [14], where the variable that was
significantly associated with delayed initiation of treatment
in the health system was an age greater than 45 years (the
prevalence of an age > 45 years was 59%). A previous study
in the HCPA showed that the prevalence of an age greater
than 45 years in patients with TB was 60% [15]. There-
fore, considering a difference between the proportions
in groups (patient delay [≥ 30 days versus < 30 days] and
health system delay [≥ 18 days versus < 18 days]) of 25%,
with the lower proportion of 40%, α = 0.05, and β = 20%,
the total number of patients needed to be studied was 69
in each group.
The median patient delay and health care system delay
were used to dichotomize the sample for analysis. Pa-
tients were evaluated according to patient delay (group
1: ≥ 30 days versus group 2: < 30 days) and health system
delay (group 1: ≥ 18 days versus group 2: < 18 days). Data
analysis was performed using SPSS 18.0 (Statistical Package
for the Social Sciences, Chicago, IL). Data are shown as the
number of cases, mean ± standard deviation (SD), or me-
dian with interquartile range (IQR). Categorical compari-
sons were performed by the chi-square test using Yates’s
correction if indicated or by Fisher’s exact test. Continuous
variables were compared using the t-test or Wilcoxon test.
Multivariate logistic regression analysis was used to evalu-
ate risk factors for patient and health care system delays.
Multivariate logistic regression modeling attempted to use
all factors associated (p < 0.10) with the outcome in univar-
iate models. Stepwise logistic regression, with entry criteria
of p < 0.10 and removal criteria of p > 0.05, was used to es-
tablish the final multivariate predictive model. This type of
variable selection with bivariable selection is frequently
used because nonsignificant risk factors in bivariable ana-
lysis may actually be significant risk factors in multi-
variable analysis. If the statistical p value of a risk factor
in bivariable analysis is greater than an arbitrary value
(often p = 0.1), then this factor will be allowed to compete
for inclusion in multivariable analysis. Hierarchical logis-
tic regression models with predictors added one at a time
were also examined to evaluate possible collinearity
among the predictors. The predictors selected in the final
model were based on numerical and clinical significance.
The goodness of fit of the multiple logistic regression
models was assessed using the Hosmer–Lemeshow test.
Odds ratios (ORs) and nominal 95% confidence intervals
(CIs) are presented. A two-sided p value < 0.05 was con-
sidered significant for all analyses.
Results
General results
From February 2010 to January 2012, 418 patients were
eligible for the study. Among pulmonary TB patients, we
excluded 248 patients who were already receiving treat-
ment at admission, 12 patients who refused to participate,
and five patients because TB diagnosis was not confirmed.
Therefore, 153 patients were included in the study.
Table 1 shows the patients’ characteristics. The me-
dian total delay (from onset of symptoms to initiation
of treatment) was 60 days. The median patient delay
was 30 days and the median health care system delay
was 18 days.
Patient delay
Table 2 shows comparative analysis for patient delay.
Compared with Group 2 (< 30 days for patient delay),
Group 1 (≥ 30 days for patient delay) had a signifi-
cantly higher proportion of cocaine use (27.8 versus 6.8%,
p = 0.001) and crack use (31.6 versus 13.5%; p = 0.013). The
proportion of patients who sought treatment at another fa-
cility before going to the ED was significantly higher in
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Group 1 than in Group 2 (82.3 versus 64.9%, p = 0.023).
In binary logistic regression analysis for patient delay, the
factors that were independently associated with a time
delay ≥ 30 days were crack use (OR = 4.88, p = 0.043) and
cocaine use (OR = 6.68, p = 0.011).
Health care system delay
Table 3 shows comparative analysis for health system delay.
The proportion of patients reporting sputum production
was significantly higher in Group 2 (< 18 days for health
care system delay) than in Group 1 (≥ 18 days for health
care system delay) (73.3 versus 55.1%, p = 0.029), and the
proportion of patients reporting previous TB (22.7 versus
9.0%, p = 0.035) and patients with fibrotic changes on chest
X-ray (17.3 versus 2.6%, p = 0.005). In multivariate ana-
lysis, the factors that were independently associated with
a time delay ≥ 18 days were weight loss (OR = 2.76, p =
0.025), chest radiography with a miliary pattern (OR = 5.33,
p = 0.032), and fibrotic changes (OR = 0.12, p = 0.013).
Discussion
This study evaluated patients diagnosed with TB in the
ED of a university hospital, in a city with a high preva-
lence of this disease. The total time from symptom onset
to the start of treatment was too long, and the delay attrib-
uted to the patient was greater than the delay attributed to
the health system. The factors that were independently as-
sociated with patient delay were cocaine and crack use.
Factors that were independently associated with health
system delay were weight loss and miliary pattern on chest
X-rays, while the presence of fibrotic changes on chest
radiography was negatively associated with health system
delay. We did not find any association between delayed
diagnosis and some factors usually associated with delay
in previous studies, such as HIV infection, negative spu-
tum smear, old age, female sex, low educational level, pov-
erty, and smoking [6].
To date, there is no consensus on an "acceptable" time
for a delay in diagnosis of TB, but it depends on the epi-
demiology and health services of each country [14]. In
underdeveloped or developing countries with highly en-
demic TB, the total time delay exceeds 120 days, while
in many developing countries, the total time delay is ap-
proximately 50 days [6].
Brazil is considered a country with high endemic TB
[1]. However, the total time delay until diagnosis of TB
that we found (60 days) in the current study is unaccept-
ably too long. A long time delay has also been reported
by studies conducted in other regions of the country
[8-10]. The southeast region reported total time delays
of 68 days [8] and 77 days [9], and a study in the north-
eastern region reported a total time of 90 days [10].
These findings indicate that in Brazil, there is a need for
greater awareness of the symptoms of TB. There is also
a need for early diagnosis of TB to attempt to reduce
this time to 3–4 weeks as recommended by international
guidelines for the control of disease [3].
In a systematic review [5], the total time delay in diag-
nosis in countries with low and highly endemic TB was
25 and 187 days, the patient delay was 4.9 and 162 days,
and the health system delay was 2 and 87 days, respect-
ively. Our study found similar time delays to those re-
ported in Brazilian studies [8,9]; the median patient delay
ranged from 30 to 56 days and the median health system
delay ranged from 14 to 21 days.
We found an association between patient delay and
drug use, particularly cocaine and crack. Patients who
Table 1 Patients’ characteristics
Characteristics n = 153
Age, years (mean ± SD) 42.6 ± 15.7
Male sex, n (%) 90 (58.8)
White race, n (%) 88 (57.5)
< 8 years schooling, n (%) 81 (52.9)
Literate, n (%) 141 (92.2)
Living alone, n (%) 30 (19.6)
Belief in a religion, n (%) 126 (82.4)
Monthly household income< 1 standard minimum
wage*, n (%)
51 (33.3)
Living in Porto Alegre, n (%) 101 (66.0)
Institutionalization, n (%) 23 (15)
Smoking habit, n (%)
Never smoker 55 (35.9)
Current smoker 42 (27.5)
Former smoker 56 (36.6)
Alcoholism, n (%) 53 (34.6)
Drug use, n (%) 50 (32.7)
Marijuana, n (%) 29 (19.0)
Cocaine use, n (%) 27 (17.6)
Crack use, n (%) 35 (22.9)
HIV positive, n (%) 77 (51.1)
Non-HIV immunosuppression, n (%) 22 (14.4)
Sought care elsewhere before hospitalization, n (%) 113 (73.9)
Forms of TB, n (%)
Pulmonary TB 127 (83.0)
Milliary TB 19 (12.4)
Pleuropulmonary TB 7 (4.6)
Total time until diagnosis (days), median (IR) 60.0 (30.0-90.5)
Patient delay (days), median (IR) 30.0 (7.0-60.0)
Health care system delay (days), median (IR) 18.0 (9.0-39.5)
TB = Tuberculosis; SD = Standard deviation, n = Number of cases, HIV = Human
immunodeficiency virus, IR = Interquartile range.
*Approximately U$ 312 (2013).
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abuse substances are more susceptible to diseases and
have a greater period of transmissibility of the disease,
because they do not seek health services early, or use TB
drugs irregularly [16]. Furthermore, in accordance with
our findings, a previous study showed that drug users
had a delay in initiation of treatment compared with pa-
tients who did not use drugs [17].
Despite TB control programs’ recommendation that
diagnosis should be made at the primary health care level,
most patients are still diagnosed in hospitals, especially
public hospitals [18,19]. In 2007, in Porto Alegre, 38.98%
of TB cases were reported by hospitals [20]. In our study,
most patients with a diagnostic delay of longer than 30 days
sought other health services before a hospital. Previous
studies have shown that a delay in diagnosis is closely re-
lated to poor access to health care, either by distance from
health services or difficulties in performing exams, and
prescription of medications other than antituberculosis









OR 95% CI p Adjusted OR 95% CI p
Age, years (mean ± SD) 44.8 ± 16.0 40.2 ± 15.0 0.98 0.96-1.01 0.069 1.03 0.99-1.05 0.064
Male sex, n (%) 51 (64.6) 39 (52.7) 1.28 0.92-1.78 0.185 1.02 0.48-2.20 0.960
White race, n (%) 42 (53.2) 46 (62.2) 0.84 0.62-1.14 0.336
< 8 years schooling, n (%) 41 (51.9) 40 (54.1) 0.96 0.71-1.30 0.916
Literate, n (% sim) 73 (92.4) 68 (91.9) 1.04 0.58-1.86 0.999
Living alone, n (%) 17 (21.5) 13 (17.6) 1.12 0.79-1.61 0.681
Belief in a religion, n (%) 65 (82.3) 61 (82.4) 1.00 0.66-1.49 0.999
Monthly household income< 1 standard minimum
wage*, n (%)
28 (35.4) 23 (31.1) 1.10 0.80-1.51 0.689
Living in Porto Alegre, n (%) 49 (62.0) 52 (70.3) 0.84 0.62-1.14 0.365
Institutionalization, n (%) 13 (16.5) 10 (13.5) 1.22 0.57-2.61 0.778
Current or former smoker 56 (70.9) 42 (56.8) 1.35 0.99-1.87 0.099 0.72 0.34-1.55 0.397
Alcoholism, n (%) 27 (34.2) 26 (35.1) 0.98 0.71-1.36 1.000
Drug use, n (%) 32 (40.5) 18 (24.3) 1.40 1.04-4.25 0.05 1.68 0.73-3.88 0.225
Marijuana use, n (%) 16 (20.3) 13 (17.6) 1.09 0.75-1.57 0.828
Cocaine use, n (%) 22 (27.8) 5 (6.8) 1.80 1.38-2,34 0.001 6.68 1.54-28.9 0.011
Crack use, n (%) 25 (31.6) 10 (13.5) 1.56 1.17-2.08 0.013 4.88 1.05-22.74 0.043
Symptoms, n (%)
Cough 70 (88.6) 63 (85.1) 1.17 0.70-1.95 0.692
Night sweats 55 (69.6) 47 (63.5) 1.15 0.81-1.61 0.529
Fever 65 (82.3) 60 (81.1) 1.04 0.69-1.56 0.999
Sputum production 56 (70.9) 42 (56.8) 1.37 0.96-1.95 0.099
Hemoptysis 16 (20.3) 9 (12.2) 1.30 0.93-1.83 0.257
Weight loss 62 (78.5) 55 (74.3) 1.12 0.76-1.65 0.678
Dyspnea 52 (65.8) 43 (58.1) 1.17 0.85-1.64 0.414
Chest pain 41 (51.9) 29 (39.2) 1.28 0.94-1.74 0.157
Fatigue 32 (40.5) 21 (28.4) 1.29 0.95-1.74 0.160
HIV positive, n (%) 41 (64.1) 36 (58.1) 1.14 0.79-1.63 0.612
Non-HIV immunosuppression, n (%) 12 (15.2) 10 (13.5) 1.07 0.70-1.62 0.948
Sought care elsewhere before hospitalization, n (%) 65 (82.3) 48 (64.9) 1.64 1.05-2.58 0.023
Previous TB, n (%) 16 (20.3) 8 (10.8) 1.37 0.98-1.91 0.167
Completed treatment, n (%) 8 (50.0) 6 (75.0) 0.72 0.41-1.14 0.388
Knows someone with TB, n (%) 41 (51.9) 36 (48.6) 1.07 0.78-1.45 0.810
TB = Tuberculosis; SD = Standard deviation, n = Number of cases, HIV = Human immunodeficiency virus.
*Approximately U$ 312 (2013).
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drugs [6,10]. This may indicate the need for training pro-
fessionals at primary health care clinics to recognize TB
symptoms, allowing early diagnosis and treatment.
Another factor related to health system delay in our
study was weight loss. Similar studies have shown that
weight loss is associated with a delay in diagnosis and
treatment initiation [10,21,22]. Another study showed that
weight loss is an independent predictor for pulmonary TB
diagnosis [23]. Furthermore, the presence of radiographic
changes, such as a miliary pattern, is associated with de-
layed initiation of treatment [23,24]. However, there is the
possibility that weight loss and a military pattern on chest
X-ray are more likely to occur in someone who has had
untreated TB for a long period, and these findings may in









OR 95% CI p Adjusted OR 95% CI p
Age, years (mean ± SD) 43.8 ± 15.83 41.28 ± 15.57 0.99 0.97-1.01 0.321 0.98 0.96-1.01 0.081
Male sex, n (%) 47 (60.3) 43 (57.1) 1.06 0.77-1.76 0.839 1.16 0.53-2.4 0.720
White race, n (%) 48 (61.5) 40 (53.3) 1.18 0.85-1.64 0.388
Current or former smoker 50 (34.1) 48 (64.0) 1.01 0.72-1.38
Alcoholism, n (%) 31 (39.7) 22 (29.3) 1.24 0.92-1.69 0.324
Drug use, n (%) 26 (33.3) 24 (32.0) 1.03 0.74-1.43 0.997
Marijuana use, n (%) 16 (20.5) 13 (17.3) 1.10 0.76-1.60 0.768
Cocaine use, n (%) 17 (21.8) 10 (13.3) 1.30 0.93-1.83 0.246
Crack use, n (%) 18 (23.1) 17 (22.7) 1.01 0,70-1.46 0.999
Symptoms, n (%) Cough 66 (84.6) 67 (89.3) 0.83 0.56-1.23 0.532
Sputum production 43 (55.1) 55 (73.3) 0.69 0.51-0.93 0.029 0.45 0.20-1.01 0.052
Hemoptysis 12 (15.4) 13 (17.3) 0.93 0.60-1.45 0.555
Fever 63 (80.8) 62 (82.7) 0.94 0.64-1.38 0.925
Weight loss 65 (83.3) 52 (69.3) 1.54 0.97-2.45 0.064 2.76 1.14-6.71 0.025
Dyspnea 49 (62.8) 46 (61.3) 1.03 0.75-1.43 0.982
Night sweats 58 (74.4) 44 (58.7) 1.45 0.99-2.12 0.059 1.74 0.77-3.93 0.184
Chest pain 36 (46.2) 34 (45.3) 1.01 0.74-1.39 0.999
Fatigue 29 (37.2) 23 (30.7) 1.18 0.86-1.61 0.408
Had consultation at the first health service
sought, n (%)
72 (92.3) 74 (98.7) 0.58 0.41-0.81 0.135
Chest x-ray performed, n (%) 65 (90.3) 69 (93.2) 0.94 0.69-1.28 0.202
Previous TB, n (%) 7 (9.0) 17 (22.7) 0.53 0.28-1.01 0.035 0.50 0.15-1.66 0.256
Completed treatment, n (%) 4 (57.1) 10 (58.8) 0.95 0.27-3.35 0.999
HIV positive, n (%) 42 (60.9) 35 (61.4) 0.99 0.72-1.37 0.999
Radiographic pattern, n (%)
Cavitation 12 (15.6) 22 (29.3) 0.64 0.40-1.04 0.066 0.45 0.19-1.08 0.074
Pleural effusion 4 (5.1) 2 (2.7) 1.32 0.74-2.39 0.682
Milliary pattern 11 (14.1) 3 (4.0) 0.059 5.33 1.15-24.56 0.032
Consolidation 41 (52.6) 40 (53.3) 0.999
Fibrotic changes 2 (2.6) 13 (17.3) 0.005 0.12 0.02- 0.64 0.013
Reticular infiltrates 28 (35.9) 21 (28.0) 0.382
Forms of TB
Pulmonary TB 75 (96.2) 74 (98.7) 0.620
Pleuropulmonary TB 3 (3.8) 1 (1.3) 0.640
Pulmonary +milliary TB 12 (15.4) 7 (9.3) 0.374
TB = Tuberculosis; SD = Standard deviation, n = Number of cases, HIV = Human immunodeficiency virus, OR = Odds ratio, 95% CI = 95% confidence interval.
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fact be a result of a delay in treatment. Fibrotic changes
and previous TB were associated with a shorter time to ini-
tiation of treatment in our study. A history of previous TB
has been reported as an independent predictor for pul-
monary TB diagnosis, and fibrotic changes may be associ-
ated with some symptoms of TB, such as hemoptysis,
which facilitates the diagnosis and prompt initiation of TB
treatment [23].
Half of the patients included in our study were TB-
HIV patients. The TB-HIV co-infection rate in the city
of Porto Alegre is the highest in the country (35%) [25].
This high prevalence of TB-HIV co-infection is prob-
ably because the study hospital is a reference center
for HIV patients in South Brazil. In addition, HIV in-
fection was not significantly associated with delays in
our study. HIV is known to delay TB diagnosis because
of non-specific and atypical clinical presentation [26,27].
However, our findings are in agreement with other stud-
ies [28-30] that found no association between HIV posi-
tivity and delayed diagnosis. In a previous investigation,
HIV-positive TB patients suffered more serious symp-
toms when TB was diagnosed, which prompted them to
visit the hospital and increased the suspicion of TB by
the clinician [30].
The main limitation of the present study is that we only
used a sample of the population served by the hospital. A
control group of individuals diagnosed and treated at pri-
mary care health clinics could be useful for identifying the
factors related to a delay in diagnosis. Furthermore, the
study was conducted in a single center and referral center
in the public system, and probably included patients with
more severe disease and lower socioeconomic status.
These factors did not affect the results, but they are specif-
ically applicable to populations similar to that in our study.
In addition, we did not evaluate some factors related to
health system delay, such as the type of provider (public,
private, and complimentary), rural/urban residence, and
availability and accessibility of services. Finally, there was
the possibility of recall bias associated with the time in
days from onset of symptoms to the first clinical care.
Despite these concerns, our study still showed some inter-
esting findings.
Although we found some delay in the health care sys-
tem, patient delay appears to be more important. The
main factor associated with patient delay was drug abuse
(crack and cocaine). Drug users may have less access
to routine medical care, potentially leading to delayed
diagnosis. Moreover, in a study with marijuana users,
patients reported that despite feeling ill and having
increased coughing, they delayed seeking care until TB
was advanced [31], resulting in an extended period of in-
fectiousness [32,33]. In addition, another study demon-
strated that patients who abuse substances are less likely
to complete TB screening [34]. There is a need for public
health interventions among drug users, focusing on TB
education programs. The use of some successful strategies,
such as needle exchange programs [35,36], should also be
considered.
Conclusions
In conclusion, this study shows that in patients with TB
diagnosed in the ED, the total time from symptom onset
to TB diagnosis is too long. Additionally, patient delay
appears to be the main problem in delay in diagnosis of
TB in our study setting. The main factor associated with
patient delay is drug abuse (crack and cocaine). Control
of TB and substance abuse programs need to be closely
linked, and health interventions should focus on TB educa-
tion programs.
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